Skip to Content

Mannitol Injection

Last Updated: December 19, 2016
Status: Current

Products Affected - Description

Mannitol injection, American Regent
250 mg/mL, 50 mL vial, 25 count (NDC 00517-4050-25)

Reason for the Shortage

American Regent has mannitol injection on shortage due to manufacturing delays.

Available Products

Osmitrol injection, Baxter
50 mg/mL, 1000 mL premixed bag, 14 count (NDC 00338-0351-04)

200 mg/mL, 250 mL premixed bag, 36 count (NDC 00338-0357-02)
200 mg/mL, 500 mL premixed bag, 24 count (NDC 00338-0357-03)
 
Mannitol injection, BBraun
200 mg/mL, 250 mL premixed bag, 1 count (NDC 00264-7578-20)
200 mg/mL, 500 mL premixed bag, 1 count (NDC 00264-7578-10)
 
Mannitol injection, Fresenius Kabi
250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25)
 
Mannitol injection, Hospira
200 mg/mL, 250 mL premixed bag, 24 count (NDC 00409-7715-02)
200 mg/mL, 500 mL premixed bag, 12 count (NDC 00409-7715-03)
250 mg/mL, 50 mL vial, 25 count (NDC 00409-4031-01)

Estimated Resupply Dates

  • American Regent has mannitol 250 mg/mL 50 mL vials on back order and the company cannot estimate a release date.
  • All other marketed presentations are available.

Related Shortages

Updated

December 19 and 5, November 7, October 19, September 7, August 15 and 8, April 14, February 1, January 20 and 6, 2016; December 11, November 5, October 19 and 7, September 10, August 5, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide